Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Sep 26, 2015; 7(8): 1118-1126
Published online Sep 26, 2015. doi: 10.4252/wjsc.v7.i8.1118
Published online Sep 26, 2015. doi: 10.4252/wjsc.v7.i8.1118
Stem cells: An eventual treatment option for heart diseases
Joseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India
Joseph C Bilgimol, Lakshmanan Vengadassalapathy, Kalimuthu Selvakumar, M Ganesan, Sadananda Rao Manjunath, KMS Health Centre Private Limited, Chennai 600050, Tamilnadu, India
Subbareddy Ragupathi, Chettinad Hospital, Chennai 603103, Tamilnadu, India
Nathan S Senthil, Thermo Fisher Scientific India Private Limited, Chennai 600034, Tamilnadu, India
Author contributions: Bilgimol JC, Senthil NS and Manjunath SR prepared the paper; Ragupathi S and Vengadassalapathy L provided administrative, technical and supervisory support; Selvakumar K and Ganesan M reviewed and edited the paper.
Conflict-of-interest statement: Authors declare no potential conflict of interest towards the publication of this review article.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Sadananda Rao Manjunath, Scientist, KMS Health Centre Private Limited, No. 50, 51, Balaji Nagar, 3rd Street, Padi, Chennai 600050, Tamilnadu, India. manjunath.s@microtheraps.com
Telephone: +91-44-26543424 Fax: +91-44-22390068
Received: May 18, 2015
Peer-review started: May 20, 2015
First decision: June 24, 2015
Revised: July 4, 2015
Accepted: July 29, 2015
Article in press: August 3, 2015
Published online: September 26, 2015
Processing time: 129 Days and 22.5 Hours
Peer-review started: May 20, 2015
First decision: June 24, 2015
Revised: July 4, 2015
Accepted: July 29, 2015
Article in press: August 3, 2015
Published online: September 26, 2015
Processing time: 129 Days and 22.5 Hours
Core Tip
Core tip: Heart diseases are most common all over the world and any form of treatment would be well appreciated to enable successful well-being in the patients. Though there are enormous efforts attempted to handle heart diseases, there has been no propounded evidence so far to utilize a particular source of cells globally. In this regard, if the responses all over the world are collectively segregated to a global database, there may be options to identify the best suitable cell source that provides effective cure.